G P Clagett, E W Salzman. Show Affiliations »
Abstract
Entities: Disease Species
Mesh： See more » Administration, OralAnticoagulants/administration & dosageAnticoagulants/adverse effectsAnticoagulants/therapeutic useDextrans/administration & dosageDextrans/therapeutic useFibrinogenHeparin/administration & dosageHeparin/therapeutic useHumansPhysical Therapy ModalitiesPostoperative Complications/prevention & controlPulmonary Embolism/diagnosisPulmonary Embolism/prevention & controlRadionuclide ImagingThromboembolism/prevention & controlThrombophlebitis/diagnosisThrombophlebitis/prevention & controlWarfarin/therapeutic use
Substances： See more » AnticoagulantsDextransWarfarinFibrinogenHeparin
Year: 1974 PMID： 4585841 DOI： 10.1056/NEJM197401102900207
Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245